Nitric oxide and portal hypertension: interface of vasoreactivity and angiogenesis.
Langer
Daniel A
DA
Gastroenterology Research Unit, Department of Physiology and Tumor Biology Program, Al 2-435, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Shah
Vijay H
VH
D000818:Animals; D006801:Humans; D006975:Hypertension, Portal / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D008099:Liver / Q000098:blood supply / Q000378:metabolism; D008102:Liver Circulation / Q000502:physiology; D009389:Neovascularization, Pathologic / Q000473:pathology*; D009569:Nitric Oxide / Q000378:metabolism*; D014655:Vascular Resistance / Q000502:physiology*
D009569:Nitric Oxide